AngioDynamics sues Endovascular Engineering over alleged Hēlo Thrombectomy System patent infringement
PUBT · 04/23 21:09
Share
Listen to the news
- AngioDynamics filed patent infringement lawsuit against Endovascular Engineering in U.S. District Court for District of Delaware on April 23, 2026.
- Complaint targets E2 Hēlo Thrombectomy System for alleged use of features covered by AngioDynamics registered patents, including self-expanding funnel technology.
- AngioDynamics seeks damages plus equitable relief.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AngioDynamics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-016424), on April 23, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending